Skip to Content.
Sympa Menu

permaculture - Fw: Monsanto trying to merge with giant AHP conglomerate

permaculture@lists.ibiblio.org

Subject: permaculture

List archive

Chronological Thread  
  • From: "Guy Clark" <guyclark@socket.net>
  • To: "Permaculture Listserve" <permaculture@listserv.oit.unc.edu>
  • Subject: Fw: Monsanto trying to merge with giant AHP conglomerate
  • Date: Tue, 2 Jun 1998 11:07:16 -0500

Hello-
Someone tell me what will happen when the sharks get done eating each
other? Will they turn into Sperm whales and starting sifting the oceans of
money for us tiny Krill more than they already do? Is it too early or too
late to begin talk about Leviathan?
Namaste',
Guy Clark
Fertile Crescent Farm
310 Hartley Court
Columbia, MO 65201
573.449.GROW
guyclark@socket.net


----------
From: David Briars <dbriars@sover.net>
To: mclibel@europe.std.com
Subject: Monsanto trying to merge with giant AHP conglomerate
Date: Monday, June 01, 1998 3:06 PM

Subject: Monsanto trying to merge with giant AHP conglomerate
Date: June 1, 1998
From: http://www.ahp.com/releases/ahp_060198.htm
via Jon Baum <missposs@clark.net>

American Home Products - News and Announcements

American Home Products and Monsanto Announce Plan to Combine To
Create $96 Billion Life Sciences Company

MADISON, N.J., and ST. LOUIS, June 1 -- Monsanto Company
(NYSE: MTC) and American Home Products Corporation (NYSE: AHP) today have
announced that they have entered into a definitive agreement to combine the
two companies in a merger of equals transaction. The combined company
would
have a market capitalization in excess of $96 billion based on current
market
prices. The combined life sciences company will have a new name and strong
global businesses in pharmaceuticals, agriculture, animal health, consumer
health care and nutrition, with combined expected sales in 1998 of
approximately $23 billion.

AHP shareowners will retain their shares. Monsanto shareowners will
receive 1.15 shares in the new company for each share of Monsanto that they
currently own. Monsanto shareowners would own approximately 35 percent of
the
combined company's shares.

The combined company's board of directors will consist of 22 members, with
representation equally divided between AHP and Monsanto. Monsanto Chairman
and Chief Executive Officer Robert B. Shapiro and AHP Chairman, President
and
Chief Executive Officer John R. Stafford will be co-chairmen and co-CEOs.
They will head an office of the chairmen. Members of that group and their
current positions are Robert G. Blount, AHP senior executive vice president
and chief financial officer; Richard U. De Schutter, Monsanto vice
chairman;
Robert Essner, AHP executive vice president; and Hendrik A. Verfaillie,
Monsanto president.

Mr. Essner will head the new company's pharmaceutical business;
Mr. De Schutter its consumer health care and nutrition businesses; and
Mr. Verfaillie its agricultural and animal health businesses. Mr. Blount
will
be the new company's chief financial officer. Corporate headquarters will
be
located in Madison, New Jersey. The new company's agricultural business
will
be headquartered in St. Louis, Missouri; the pharmaceutical business
headquartered in Radnor, Pennsylvania; and the consumer health care and
nutrition businesses headquartered in Chicago, Illinois.

This new company is based on growth and opportunity. We're committed to
cutting edge science, to developing and marketing great products, and to a
philosophy of growth and value," said Mr. Stafford.

Mr. Shapiro stated, "Our new company is designed to be successful in the
face of continued consolidation and increasing worldwide competition in the
life sciences. We will have the scientific depth, global marketing
capabilities and financial resources to take greater advantage of the
opportunities before us and to bring innovative new products to market
faster."

As a result of the merger, the companies expect to realize on an annual
basis between $1.25 billion and $1.5 billion in cost savings from synergies
and cost avoidance within three years from the closing. From the
standpoint
of AHP's earnings, assuming the merger is consummated by year end 1998 and
after synergies and cost savings, earnings per share are anticipated to be
diluted by up to 15 percent in the first year, by a lesser amount in 2000,
and
accretive thereafter.

The transaction is subject to approval by both companies' shareowners,
normal governmental reviews and other customary conditions. The merger is
intended to qualify as a tax-free reorganization and to be accounted for on
a
pooling of interests basis.

Monsanto is a life sciences company, committed to finding solutions to the
growing global needs for food and health by applying advanced bioscience
and
biotechnology to agriculture, nutrition and health. It makes and
manufactures
high-value agricultural products, pharmaceuticals and food ingredients.

AHP is one of the world's largest research-based pharmaceutical and health
care products companies. It is a leader in the discovery, development,
manufacturing and marketing of prescription drugs and over-the-counter
medications. It is also a global leader in vaccines, biotechnology,
agricultural products and animal health care.

This news release contains certain forward-looking statements, including,
among other things, statements regarding each company's results of
operations
and expected cost savings and earnings per share effects. These
forward-looking statements are based on current expectations, but actual
results may differ materially from anticipated future events or results.
Certain factors which could cause each company's actual results to differ
materially from expected and historical results are described in AHP's and
Monsanto's periodic reports filed with the Securities and Exchange
Commission,
including Monsanto's and AHP's 1997 annual reports and Forms 10-K and
Exhibits
99 thereto, respectively.

This announcement is not an offer to sell nor a solicitation to buy any
securities. The offering with respect to the proposed merger will be made
only by the proxy statement/prospectus that will be distributed to
shareowners
in connection with their consideration of the transaction.


CONTACTS: Amewrican Home Products &#150; Media: Lowell B. Weiner (973)
660-5013. Investor: Thomas G. Cavanagh (973) 660-5706<br>Monsanto &#150;
Media, Scarlett Lee Foster of Monsanto 314-694-2883 or
mailto:scarlett.l.foster@monsanto.com
1-----------------------------------------------------------------------
U.S. McLibel Support Campaign Email dbriars@sover.net
PO Box 62 Phone/Fax 802-586-9628
Craftsbury VT 05826-0062 http://www.mcspotlight.org/
Archive: <http://www.envirolink.org/arrs/maiLists/mclibel/>
-----------------------------------------------------------------------
To subscribe to the "mclibel" electronic mailing list, send email

To: majordomo@world.std.com
Subject: <not needed>
Message: subscribe mclibel

To unsubscribe, change the message to: "unsubscribe mclibel"



  • Fw: Monsanto trying to merge with giant AHP conglomerate, Guy Clark, 06/02/1998

Archive powered by MHonArc 2.6.24.

Top of Page